• 早期研究已经显示,对慢性乙型肝炎e抗原阴性患者进行48周阿德治疗后,获得了临床上改善

    Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.

    youdao

  • 早期研究已经显示,对慢性乙型肝炎e抗原阴性患者进行48周阿德治疗后,获得了临床上改善

    Early research has shown that a 48-week course of adefovir provides clinical improvements in patients with HBeAg-negative chronic hepatitis B.

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定